Clinical Trial Update: A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral asciminib to other TKIs in adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase

Drugs mentioned

• Asciminib (asciminib)
• Other TKIs

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-10